Novartis Alpelisib-Piqray Price

Alpelisib (Alpelisib)-PiqrayThe original drug is not marketed in China, so it cannot be included in medical insurance. There are European and Indian versions of the original drug Apelvis sold overseas, both developed and produced by Novartis Pharmaceuticals of Switzerland. Its drug ingredients are basically the same and can be used in combination with fulvestrant to treat postmenopausal women and men PIK3CA-mutated, advanced or metastatic breast cancer. European version specification The price of 150mg*56 tablets per box may be more than 40,000 RMB (the price may fluctuate due to exchange rate effects), while the Indian version specification of 150mg*28 tablets may be priced at more than 5,000 RMB per box (price may fluctuate due to exchange rate effects). There are currently no generic versions of Apelvis produced and marketed.